The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Quantitative hormone receptors, triple-negative breast cancer (TNBC), and molecular subtypes: A collaborative effort of the BIG-NCI NABCG.
Maggie Chon U. Cheang
No relevant relationships to disclose
Miguel Martin
No relevant relationships to disclose
Torsten O. Nielsen
Stock Ownership - Bioclassifier
Research Funding - NanoString Technologies
Aleix Prat
No relevant relationships to disclose
Alvaro Rodriguez-Lescure
No relevant relationships to disclose
Amparo Ruiz
No relevant relationships to disclose
Stephen K. L. Chia
No relevant relationships to disclose
Lois E. Shepherd
No relevant relationships to disclose
David Voduc
No relevant relationships to disclose
Philip Seth Bernard
Employment or Leadership Position - University Genomics (U)
Consultant or Advisory Role - University Genomics (U)
Stock Ownership - Bioclassifier
Matthew James Ellis
Employment or Leadership Position - Bioclassifier (U)
Consultant or Advisory Role - NanoString Technologies (U)
Stock Ownership - Bioclassifier
Charles M. Perou
Employment or Leadership Position - University Genomics (U)
Stock Ownership - Bioclassifier (B)
Angelo Di Leo
No relevant relationships to disclose
Lisa A. Carey
No relevant relationships to disclose